Iron status and fibroblast growth factor-23 in Gambian children

Vickie Braithwaite1, Landing M A Jarjou, Gail R Goldberg

  • 1Medical Research Council (MRC) Human Nutrition Research, Cambridge, UK. Vickie.braithwaite@mrc-hnr.cam.ac.uk

Bone
|April 3, 2012
PubMed

Insights

Iron deficiency anemia is common in The Gambia. This study found a stronger link between fibroblast growth factor-23 (FGF23) and hemoglobin in Gambian children with rickets, suggesting iron

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Biochemistry
  • Bone Metabolism

Background:

  • Iron deficiency anemia is prevalent in The Gambia.
  • Elevated fibroblast growth factor-23 (FGF23) is observed in Gambian children with rickets-like bone deformities.
  • Low iron status is hypothesized to contribute to the etiology of Gambian rickets.

Purpose of the Study:

  • To investigate the relationship between hemoglobin, as a marker of iron status, and FGF23.
  • To determine if this relationship differs between children with and without a history of rickets-like bone deformities in The Gambia.

Main Methods:

  • Retrospective analysis of data from 2006-2008 in a rural Gambian community.
  • Age-adjusted linear regression modeling was used to analyze FGF23 and hemoglobin concentrations.
  • Data included children with rickets-like bone deformity (n=108) and local community children (n=382).

Main Results:

  • Circulating FGF23 concentration was inversely correlated with hemoglobin concentration.
  • This inverse correlation was more pronounced in children with bone deformities compared to the local community.
  • Anemia and elevated FGF23 were significantly more prevalent in children with bone deformities.

Conclusions:

  • A stronger relationship exists between FGF23 and hemoglobin in Gambian children with a history of rickets.
  • These findings support the hypothesis that iron plays a role in FGF23 metabolic pathways.
  • Iron status may be implicated in the pathogenesis of rickets in Gambian children.

Related Concept Videos